Amarillo Biosciences, Inc. (OTCMKTS:AMAR – Get Free Report) dropped 14.3% during trading on Monday . The company traded as low as $0.60 and last traded at $0.60. Approximately 6,100 shares changed hands during trading, a decline of 67% from the average daily volume of 18,253 shares. The stock had previously closed at $0.70.
Amarillo Biosciences Stock Performance
The business has a 50 day moving average of $0.60.
Amarillo Biosciences Company Profile
Amarillo Biosciences, Inc, a healthcare company, engages in the discovery and development of pharmaceutical and biotech products in the United States and Asia. The company operates in three divisions: Pharmaceutical, Medical, and Consumer. The Pharmaceutical division offers low-dose non-injectable interferon (IFN) for the treatment of neoplastic, viral, and fibrotic diseases.
Read More
- Five stocks we like better than Amarillo Biosciences
- 3 Warren Buffett Stocks to Buy Now
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Canada Bond Market Holiday: How to Invest and Trade
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Amarillo Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amarillo Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.